Home > News > Amid Confusion, Nanotech Industry Awaits Boom
September 25th, 2007
Amid Confusion, Nanotech Industry Awaits Boom
What has been lacking is a wave of nanotech initial public offerings, which would herald the industry's arrival to investors. The disappointing pace of deals in the sector reflects problems in the IPO market, according to Mr. Harris, as much as the sometimes confusing evolution of nanotech products.
Last year only 56 venture capital-backed companies went public in America, down from 250 in 1999. Venture capital has been upstaged by private equity in recent years, in part because the latter sector has profited better from the liquid credit markets. Private equity deals have become increasingly leveraged and have consequently produced outsized returns for investors, while venture capital firms have traditionally been loath to add to the already risky nature of their investments by borrowing. Also, the huge and ultimately catastrophic boom in technology venture capital in the late 1990s left a distinctly sour taste in the public's mouth. Needless to say, the current seizing up of the credit markets could change the playing field.
Malaysian Nanotechnology Company Nanopac Innovation Ltd. lists on the NSX January 19th, 2015
Aspen Aerogels, Inc. to Present at the Needham Growth Conference January 8th, 2015
Blend Therapeutics Secures $21 Million Financing and Unveils Novel Pentarin™ Platform for Cancer Therapeutics: Company’s Technology and Expertise in Cancer R&D Evolve to Create New Class of Miniaturized Biologic Drug Conjugates (mBDCs) Encapsulated in Nanoparticles January 8th, 2015
Nanometrics to Announce Fourth Quarter and Full Year Financial Results on February 2, 2015 January 7th, 2015
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Iranian Scientists Use MOFs to Eliminate Dye Pollutants January 29th, 2015
Made-in-Singapore rapid test kit detects dengue antibodies from saliva: IBN's MedTech innovation simplifies diagnosis of infectious diseases January 29th, 2015
Nanoparticles that deliver oligonucleotide drugs into cells described in Nucleic Acid Therapeutics January 28th, 2015
'Bulletproof' battery: Kevlar membrane for safer, thinner lithium rechargeables January 28th, 2015